Si-Bone (SIBN) Interest & Investment Income (2017 - 2026)
Si-Bone's (SIBN) quarterly Interest & Investment Income came in at $1.3 million in Q1 2026, down 15.2% year-on-year from $1.6 million in Q1 2025, and down 6.7% quarter-over-quarter from $1.4 million in Q4 2025.
Si-Bone (SIBN) Interest & Investment Income (2017 - 2026) Analysis & Trends
Si-Bone's Interest & Investment Income history runs 10 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 15.2% year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $5.8 million, a 20.4% decrease from a year earlier, with the FY2025 full-year figure at $6.1 million, down 22.6% from the prior year.
- Interest & Investment Income fell to $1.3 million in Q1 2026 per SIBN's latest filing, from $1.4 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $2.2 million in Q4 2023 and bottomed at $73000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $1.5 million (2025), against an average of $1.4 million.
- Across the five-year window, Interest & Investment Income jumped 2040.0% in 2022 and retreated 24.66% in 2025, its largest moves.
- Year by year, Interest & Investment Income stood at $749000.0 in 2022, then soared by 197.33% to $2.2 million in 2023, then fell by 19.89% to $1.8 million in 2024, then slipped by 18.89% to $1.4 million in 2025, then declined by 6.7% to $1.3 million in 2026.
- Per Business Quant, the three latest SIBN Interest & Investment Income figures stand at $1.3 million (Q1 2026), $1.4 million (Q4 2025), and $1.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | Si-Bone | 753.03 Mn | 608.35 Mn | 41.94 Mn | 1.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.35 Mn |
| Dec 31, 2025 | 1.45 Mn |
| Sep 30, 2025 | 1.52 Mn |
| Jun 30, 2025 | 1.52 Mn |
| Mar 31, 2025 | 1.59 Mn |
| Dec 31, 2024 | 1.78 Mn |
| Sep 30, 2024 | 1.94 Mn |
| Jun 30, 2024 | 2.02 Mn |
| Mar 31, 2024 | 2.11 Mn |
| Dec 31, 2023 | 2.23 Mn |
| Sep 30, 2023 | 2.17 Mn |
| Jun 30, 2023 | 1.58 Mn |
| Mar 31, 2023 | 932,000.00 |
| Dec 31, 2022 | 749,000.00 |
| Sep 30, 2022 | 346,000.00 |
| Jun 30, 2022 | 136,000.00 |
| Mar 31, 2022 | 73,000.00 |
| Dec 31, 2021 | 35,000.00 |
| Sep 30, 2021 | 44,000.00 |
| Jun 30, 2021 | 46,000.00 |